blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2802673

EP2802673 - METHODS AND BIOMARKERS FOR ANALYSIS OF COLORECTAL CANCER [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.07.2020
Database last updated on 27.07.2024
FormerThe patent has been granted
Status updated on  31.05.2019
FormerGrant of patent is intended
Status updated on  07.02.2019
FormerExamination is in progress
Status updated on  01.02.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Oslo Universitetssykehus HF
Postboks 450
Nydalen
0424 Oslo / NO
[2014/47]
Inventor(s)01 / LOTHE, Ragnhild, A.
Erling Skjalgssons Gate 23 E
N-0267 Oslo / NO
02 / SVEEN, Anita
Hasleveien 26
N-0571 Oslo / NO
03 / AGESEN, Trude, Holmeide
Myrerveien 31A
N-0494 Oslo / NO
04 / LIND, Guro, Elisabeth
Pilotveien 10
N-0770 Oslo / NO
05 / NESBAKKEN, Arild
Prestegardsjordet 28
N-3440 Royken / NO
06 / SKOTHEIM, Rolf, Inge
Gaustadveien 8d
N-0372 Oslo / NO
 [2015/08]
Former [2014/47]01 / LOTHE, Ragnhild, A.
Erling Skjalgssons Gate 23 E
N-0267 Oslo / NO
02 / SVEEN, Anita
Hasleveien 26
N-0571 Oslo / NO
03 / AGESEN, Trude, Holmeide
Kjelsasveien 95 D
N-0491 Oslo / NO
04 / LIND, Guro, Elisabeth
Pilotveien 10
N-0770 Oslo / NO
05 / NESBAKKEN, Arild
Prestegardsjordet 28
N-3440 Royken / NO
06 / SKOTHEIM, Rolf, Inge
Gaustadveien 8d
N-0372 Oslo / NO
Representative(s)Algemeen Octrooi- en Merkenbureau B.V.
P.O. Box 645
5600 AP Eindhoven / NL
[2014/47]
Application number, filing date13715747.509.01.2013
[2019/27]
WO2013IB00391
Priority number, dateUS201261584540P09.01.2012         Original published format: US 201261584540 P
[2014/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013104990
Date:18.07.2013
Language:EN
[2013/29]
Type: A1 Application with search report 
No.:EP2802673
Date:19.11.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 18.07.2013 takes the place of the publication of the European patent application.
[2014/47]
Type: B1 Patent specification 
No.:EP2802673
Date:03.07.2019
Language:EN
[2019/27]
Search report(s)International search report - published on:EP18.07.2013
ClassificationIPC:C12Q1/6886
[2019/07]
CPC:
C12Q1/6886 (EP,US); C12Q2600/118 (US); C12Q2600/158 (EP,US)
Former IPC [2014/47]C12Q1/68
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/47]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERFAHREN UND BIOMARKER ZUR ANALYSE VON KOLOREKTALKARZINOMEN[2014/47]
English:METHODS AND BIOMARKERS FOR ANALYSIS OF COLORECTAL CANCER[2014/47]
French:PROCÉDÉS ET BIOMARQUEURS POUR L'ANALYSE D'UN CANCER COLORECTAL[2014/47]
Entry into regional phase17.07.2014National basic fee paid 
17.07.2014Designation fee(s) paid 
17.07.2014Examination fee paid 
Examination procedure17.07.2014Amendment by applicant (claims and/or description)
17.07.2014Examination requested  [2014/47]
29.07.2015Despatch of a communication from the examining division (Time limit: M06)
04.02.2016Reply to a communication from the examining division
21.07.2016Despatch of a communication from the examining division (Time limit: M06)
31.01.2017Reply to a communication from the examining division
19.04.2018Cancellation of oral proceeding that was planned for 23.04.2018
23.04.2018Date of oral proceedings (cancelled)
04.05.2018Despatch of a communication from the examining division (Time limit: M05)
03.10.2018Reply to a communication from the examining division
08.02.2019Communication of intention to grant the patent
20.05.2019Fee for grant paid
20.05.2019Fee for publishing/printing paid
20.05.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  29.07.2015
Opposition(s)03.06.2020No opposition filed within time limit [2020/33]
Fees paidRenewal fee
27.01.2015Renewal fee patent year 03
27.01.2016Renewal fee patent year 04
27.01.2017Renewal fee patent year 05
29.01.2018Renewal fee patent year 06
28.01.2019Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.01.2013
AL03.07.2019
AT03.07.2019
CY03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
ES03.07.2019
FI03.07.2019
HR03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
MC03.07.2019
MK03.07.2019
MT03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
RS03.07.2019
SE03.07.2019
SI03.07.2019
SK03.07.2019
SM03.07.2019
TR03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
IE09.01.2020
LU09.01.2020
BE31.01.2020
CH31.01.2020
LI31.01.2020
[2022/32]
Former [2022/27]HU09.01.2013
AL03.07.2019
AT03.07.2019
CY03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
ES03.07.2019
FI03.07.2019
HR03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
MC03.07.2019
MT03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
RS03.07.2019
SE03.07.2019
SI03.07.2019
SK03.07.2019
SM03.07.2019
TR03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
IE09.01.2020
LU09.01.2020
BE31.01.2020
CH31.01.2020
LI31.01.2020
Former [2021/08]AL03.07.2019
AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
ES03.07.2019
FI03.07.2019
HR03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
MC03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
RS03.07.2019
SE03.07.2019
SI03.07.2019
SK03.07.2019
SM03.07.2019
TR03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
IE09.01.2020
LU09.01.2020
BE31.01.2020
CH31.01.2020
LI31.01.2020
Former [2020/51]AL03.07.2019
AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
ES03.07.2019
FI03.07.2019
HR03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
MC03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
RS03.07.2019
SE03.07.2019
SI03.07.2019
SK03.07.2019
SM03.07.2019
TR03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
LU09.01.2020
BE31.01.2020
CH31.01.2020
LI31.01.2020
Former [2020/48]AL03.07.2019
AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
ES03.07.2019
FI03.07.2019
HR03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
MC03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
RS03.07.2019
SE03.07.2019
SI03.07.2019
SK03.07.2019
SM03.07.2019
TR03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
LU09.01.2020
Former [2020/46]AL03.07.2019
AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
FI03.07.2019
HR03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
MC03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
RS03.07.2019
SE03.07.2019
SI03.07.2019
SK03.07.2019
SM03.07.2019
TR03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
LU09.01.2020
Former [2020/39]AL03.07.2019
AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
FI03.07.2019
HR03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
MC03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
RS03.07.2019
SE03.07.2019
SI03.07.2019
SK03.07.2019
SM03.07.2019
TR03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
Former [2020/37]AL03.07.2019
AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
FI03.07.2019
HR03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
RS03.07.2019
SE03.07.2019
SI03.07.2019
SK03.07.2019
SM03.07.2019
TR03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
Former [2020/36]AL03.07.2019
AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
FI03.07.2019
HR03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
RS03.07.2019
SE03.07.2019
SK03.07.2019
SM03.07.2019
TR03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
Former [2020/27]AL03.07.2019
AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
FI03.07.2019
HR03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
RS03.07.2019
SE03.07.2019
SK03.07.2019
SM03.07.2019
TR03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
PT04.11.2019
IS24.02.2020
Former [2020/25]AL03.07.2019
AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
FI03.07.2019
HR03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
RS03.07.2019
SE03.07.2019
SK03.07.2019
TR03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
PT04.11.2019
IS24.02.2020
Former [2020/24]AL03.07.2019
AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
FI03.07.2019
HR03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
RS03.07.2019
SE03.07.2019
TR03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
PT04.11.2019
IS24.02.2020
Former [2020/23]AL03.07.2019
AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
FI03.07.2019
HR03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
RS03.07.2019
SE03.07.2019
TR03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
Former [2020/22]AL03.07.2019
AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
FI03.07.2019
HR03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
RS03.07.2019
SE03.07.2019
TR03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
Former [2020/17]AL03.07.2019
AT03.07.2019
CZ03.07.2019
FI03.07.2019
HR03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
RS03.07.2019
SE03.07.2019
TR03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
Former [2020/15]AL03.07.2019
AT03.07.2019
CZ03.07.2019
FI03.07.2019
HR03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
RS03.07.2019
SE03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
Former [2020/12]AT03.07.2019
CZ03.07.2019
FI03.07.2019
HR03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
RS03.07.2019
SE03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
Former [2020/11]AT03.07.2019
CZ03.07.2019
FI03.07.2019
HR03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
RS03.07.2019
SE03.07.2019
BG03.10.2019
NO03.10.2019
GR04.10.2019
PT04.11.2019
Former [2020/10]AT03.07.2019
CZ03.07.2019
FI03.07.2019
LT03.07.2019
NL03.07.2019
SE03.07.2019
BG03.10.2019
NO03.10.2019
PT04.11.2019
Former [2020/09]CZ03.07.2019
FI03.07.2019
LT03.07.2019
NL03.07.2019
NO03.10.2019
Former [2020/08]LT03.07.2019
NL03.07.2019
NO03.10.2019
Former [2020/07]NL03.07.2019
Cited inInternational search[A]WO2007082099  (GENOMIC HEALTH INC [US], et al) [A] 1-33 * claims 35, 36; Table 1A *;
 [X]US2011097423  (BEAUCHAMP R DANIEL [US], et al) [X] 31 * Fig. 2A, 4A, 4B; par. 200; claims 1, 2, 6, 7 *;
 [XI]  - KASAMATSU A ET AL, "Identification of candidate genes associated with salivary adenoid cystic carcinomas using combined comparative genomic hybridization and oligonucleotide microarray analyses", INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND CELL BIOLOGY, PERGAMON, GB, vol. 37, no. 9, ISSN 1357-2725, (20050901), pages 1869 - 1880, (20050901), XP027742022 [X] 22-27 * page 1871, right col. * [I] 28-30
 [XI]  - KUROKAWA K ET AL, Brief naturalistic stress induces an alternative splice variant of SMG-1 lacking exon 63 in peripheral leukocytes, NEUROSCIENCE LETTERS, LIMERICK, IE, PAGE(S) 128 - 132, (20101029), ISSN 0304-3940, XP027299415 [X] 22-27 * abstract * [I] 28-30
 [IA]  - GREENBAUM D ET AL, "COMPARING PROTEIN ABUNDANCE AND MRNA EXPRESSION LEVELS ON A GENOMIC SCALE", GENOME BIOLOGY (ONLINE), BIOMED CENTRAL LTD, GB, (20030101), vol. 40, no. 9, ISSN 1465-6914, pages 117.01 - 117.08, XP008036618 [I] 32,33 * page 117.4, left and right col. * [A] 1-31
 [IA]  - GREENBAUM DOV ET AL, "Interrelating different types of genomic data, from proteome to secretome: 'Oming in on function", GENOME RESEARCH, COLD SPRING HARBOR LABORATORY PRESS, WOODBURY, NY, US, (20010901), vol. 11, no. 9, doi:10.1101/GR.207401, ISSN 1088-9051, pages 1463 - 1468, XP009088703 [I] 32,33 * page 1467, right col. * [A] 1-31

DOI:   http://dx.doi.org/10.1101/gr.207401
 [IA]  - OERNTOFT T F ET AL, "GENOME-WIDE STUDY OF GENE COPY NUMBERS, TRANSCRIPTS, AND PROTEIN LEVELS IN PAIRS OF NON-INVASIVE AND INVASIVE HUMAN TRANSITIONAL CELL CARCINOMAS", MOLECULAR & CELLULAR PROTEOMICS, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, INC, US, (20020101), vol. 1, no. 1, doi:10.1074/MCP.M100019-MCP200, ISSN 1535-9476, pages 37 - 45, XP008015037 [I] 32,33 * page 44, right col. * [A] 1-31

DOI:   http://dx.doi.org/10.1074/mcp.M100019-MCP200
 [XI]  - AGESEN TRUDE H ET AL, "ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis", GUT, BRITISH MEDICAL ASSOCIATION, LONDON, UK, (20120102), vol. 61, no. 11, ISSN 0017-5749, pages 1560 - 1567, XP009168202 [X] 1,21 * the whole document * [I] 2-20

DOI:   http://dx.doi.org/10.1136/gutjnl-2011-301179
 [X]  - D. BESSON ET AL, "A Quantitative Proteomic Approach of the Different Stages of Colorectal Cancer Establishes OLFM4 as a New Nonmetastatic Tumor Marker", MOLECULAR & CELLULAR PROTEOMICS, (20111201), vol. 10, no. 12, doi:10.1074/mcp.M111.009712, ISSN 1535-9476, XP055065230 [X] 1,21 * page 1429, right col.; Fig. 2A *

DOI:   http://dx.doi.org/10.1074/mcp.M111.009712
by applicantUS4458066
 US4683195
 US4683202
 US4800159
 US4965188
 US5130238
 US5225326
 US5270184
 US5283174
 US5338671
 US5399491
 US5455166
 EP0684315
 US5480784
 US5494810
 US5508169
 US5545524
 US5639611
 US5695934
 US5710029
 US5714330
 US5750341
 US5770370
 US5773258
 US5814447
 US5824518
 US5912148
 US5925517
 US5928862
 US5965408
 WO0018957
 US6121489
 US6130073
 US6150097
 US6210891
 US6258568
 US6303305
 US6306597
 US6432360
 US6485944
 US6511803
 US6534274
 US6541205
 US6573043
 EP1409727
 US6787308
 US6818395
 US6833246
 US2005042638
 WO2005023091
 US2005130173
 US6911345
 US6969488
 US2006046265
 WO2006084132
 US7115400
 US7169560
 US2007202525
 US7282337
 US7329492
 US2008076121
 US7482120
 US2009026082
 US2009035777
 US7501245
 US2009127589
 US7662594
 US2010137143
 US2010188073
 US2010197507
 US2010301398
 EP2290101
 US2011104693
    - "Colon cancer: Management of locoregional disease", VAN CUTSEM ET AL., Principles and practice of gastrointestinal oncology, LIPPINCOTT WILLIAMS & WILKINS, (2008), page 581
    - GRAY ET AL., LANCET, (2007), vol. 370, pages 2020 - 2029
    - ANDRE ET AL., ANN SURG ONCOL, (2006), vol. 13, pages 887 - 898
    - SOBRERO A, LANCET ONCOL, (2006), vol. 7, pages 515 - 516
    - KOHNE, LANCET ONCOL, (2006), vol. 7, pages 516 - 517
    - BENSON ET AL., J CLIN ONCOL, (2004), vol. 22, pages 3408 - 3419
    - ANDRE ET AL., N ENGL J MED, (2004), vol. 350, pages 2343 - 2351
    - O'CONNELL ET AL., J NATL CANCER INST, (2004), vol. 96, pages 1420 - 1425
    - LOCKER ET AL., ASCO 2006 J ONCOL PRACT, (2006), vol. 24, pages 5313 - 5327
    - TRIGLIA ET AL., NUCLEIC ACIDS RES., (1988), vol. 16, page 8186
    - GUILFOYLE, R. ET AL., NUCLEIC ACIDS RESEARCH, (1997), vol. 25, pages 1854 - 1858
    - HERMAN ET AL., PNAS, (1996), vol. 93, no. 13, pages 9821 - 9826
    - SCHOUTEN ET AL., NUCLEIC ACIDS RESEARCH, (2002), vol. 30, no. 12, page E57
    - CHAMBERLAIN ET AL., NUCLEIC ACIDS RESEARCH, (1988), vol. 16, no. 23, pages 11141 - 11156
    - BALLABIO ET AL., HUMAN GENETICS, (1990), vol. 84, no. 6, pages 571 - 573
    - HAYDEN ET AL., BMC GENETICS, (2008), vol. 9, page 80
    - HIGUCHI ET AL., NUCLEIC ACIDS RESEARCH, (1988), vol. 16, no. 15, pages 7351 - 7367
    - HIGUCHI, BIOTECHNOLOGY, (1992), vol. 10, pages 413 - 417
    - HIGUCHI ET AL., BIOTECHNOLOGY, (1993), vol. 11, pages 1026 - 1030
    - BUSTIN, S.A., J. MOLECULAR ENDOCRINOLOGY, (2000), vol. 25, pages 169 - 193
    - DON ET AL., NUCLEIC ACIDS RESEARCH, (1991), vol. 19, no. 14, page 4008
    - ROUX, K., BIOTECHNIQUES, (1994), vol. 16, no. 5, pages 812 - 814
    - HECKER ET AL., BIOTECHNIQUES, (1996), vol. 20, no. 3, pages 478 - 485
    - KALININA ET AL., NUCLEIC ACIDS RESEARCH, (1997), vol. 25, pages 1999 - 2004
    - VOGELSTEIN; KINZLER, PROC NATL ACAD SCI USA., (1999), vol. 96, pages 9236 - 41
    - NARANG ET AL., METH ENZYMOL., (1979), vol. 68, pages 90 - 99
    - BROWN ET AL., METH ENZYMOL., (1979), vol. 68, pages 109 - 151
    - BEAUCAGE ET AL., TETRAHEDRON LETT., (1981), vol. 22, pages 1859 - 1862
    - MATTEUCCI ET AL., J AM CHEM SOC., (1981), vol. 103, pages 3185 - 3191
    - GLAS ET AL., BMC GENOMICS, (2006), vol. 7, page 278
    - ARANGO ET AL., GASTROENTEROLOGY, (2005), vol. 129, pages 874 - 884
    - BARRIER ET AL., J CLIN ONCOL, (2006), vol. 24, pages 4685 - 4690
    - BERTUCCI ET AL., ONCOGENE, (2004), vol. 23, pages 1377 - 1391
    - ESCHRICH ET AL., J CLIN ONCOL, (2005), vol. 23, pages 3526 - 3535
    - WANG ET AL., J CLIN ONCOL, (2004), vol. 22, pages 1564 - 1571
    - LU ET AL., CLIN COLORECTAL CANCER, (2009), vol. 8, pages 207 - 214
    - JORISSEN ET AL., CLIN CANCER RES, (2009), vol. 15, pages 7642 - 7651
    - O'CONNELL ET AL., J CLIN ONCOL, (2010), vol. 28, pages 3937 - 3944
    - SALAZAR ET AL., J CLIN ONCOL, (2011), vol. 29, pages 17 - 24
    - SMITH ET AL., GASTROENTEROLOGY, (2010), vol. 138, pages 958 - 968
    - GOEMAN ET AL., BIOM J, (2009), vol. 52, pages 70 - 84
    - VAN HOUWELINGEN ET AL., STAT MED, (2006), vol. 25, pages 3201 - 3216
    - GOEMAN, BIOM J, (2009), vol. 52, pages 70 - 84
    - TIBSHIRANI J R, STATIST SOC B, (1996), vol. 58, pages 267 - 288
    - TIBSHIRANI, STAT MED, (1997), vol. 16, pages 385 - 395
    - KERR ET AL., J CLIN ONCOL, (2009), vol. 27, page 4000
    - WEBBER ET AL., PLOS CURR, (2010), vol. 2, page RRN1177
    - NSES ET AL., J CHEMOM, (2001), vol. 15, pages 413 - 426
    - KOSCIELNY, SCI TRANSL MED, (2010), vol. 2, page 14PS2
    - HAIBE-KAINS ET AL., BIOINFORMATICS, (2008), vol. 24, pages 2200 - 2208
    - SANGER ET AL., PROC. NATL. ACAD. SCI. USA, (1997), vol. 74, pages 5463 - 5467
    - MAXAM ET AL., PROC. NATL. ACAD. SCI. USA, (1977), vol. 74, pages 560 - 564
    - DRMANAC ET AL., NAT. BIOTECHNOL., (1998), vol. 16, pages 54 - 58
    - KATO, INT. J. CLIN. EXP. MED., (2009), vol. 2, pages 193 - 202
    - RONAGHI ET AL., ANAL. BIOCHEM., (1996), vol. 242, pages 84 - 89
    - MARGULIES ET AL., NATURE, (2005), vol. 437, pages 376 - 380
    - RUPAREL ET AL., PROC. NATL. ACAD. SCI. USA, (2005), vol. 102, pages 5932 - 5937
    - HARRIS ET AL., SCIENCE, (2008), vol. 320, pages 106 - 109
    - LEVENE ET AL., SCIENCE, (2003), vol. 299, pages 682 - 686
    - KORLACH ET AL., PROC. NATL. ACAD. SCI. USA, (2008), vol. 105, pages 1176 - 1181
    - BRANTON ET AL., NAT. BIOTECHNOL., (2008), vol. 26, no. 10, pages 1146 - 53
    - EID ET AL., SCIENCE, (2009), vol. 323, pages 133 - 138
    - MOROZOVA; MARRA, "provide a review of some such technologies", GENOMICS, (2008), vol. 92, page 255
    - BIRREN ET AL., Genome Analysis: Analyzing DNA, COLD SPRING HARBOR, vol. 1
    - MITRA ET AL., ANALYTICAL BIOCHEMISTRY, (2003), vol. 320, pages 55 - 65
    - SHENDURE ET AL., SCIENCE, (2005), vol. 309, pages 1728 - 1732
    - BENNETT ET AL., PHARMACOGENOMICS, (2005), vol. 6, pages 373 - 382
    - BRENNER ET AL., NAT. BIOTECHNOL., (2000), vol. 18, pages 630 - 634
    - ADESSI ET AL., NUCLEIC ACID RES., (2000), vol. 28, page E87
    - VOELKERDING ET AL., CLINICAL CHEM., (2009), vol. 55, pages 641 - 658
    - MACLEAN ET AL., NATURE REV. MICROBIOL., vol. 7, pages 287 - 296
    - ASTIER ET AL., J. AM. CHEM. SOC., (20060208), vol. 128, no. 5, pages 1705 - 10
    - SCIENCE, (2010), vol. 327, no. 5970, page 1190
    - VOELKERDING ET AL., CLINICAL CHEM., (2009), vol. 55, pages 641 - 58
    - NATURE, (2001), vol. 409, pages 953 - 958
    - KUO ET AL., AM. J. HUM. GENET., (1991), vol. 49, pages 112 - 119
    - KLINGER ET AL., AM. J. HUM. GENET., (1992), vol. 51, pages 55 - 65
    - WARD ET AL., AM. J. HUM. GENET., (1993), vol. 52, pages 854 - 865
    - MULLIS ET AL., METH. ENXYLNOL., (1987), vol. 155, page 335
    - MURAKAWA ET AL., DNA, (1988), vol. 7, page 287
    - WEISS, R., SCIENCE, (1991), vol. 254, page 1292
    - WALKER, G. ET AL., PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 392 - 396
    - LIZARDI ET AL., BIOTECHNOL., (1988), vol. 6, page 1197
    - KWOH ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, page 1173
    - GUATELLI ET AL., PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, page 1874
    - "In Vitro Nucleic Acid Amplification Techniques", PERSING, DAVID H. ET AL., Diagnostic Medical Microbiology: Principles and Applications, AMERICAN SOCIETY FOR MICROBIOLOGY, (1993), pages 51 - 87
    - BERG ET AL., PLOS ONE, (2010), vol. 5, page EL3978
    - THORSTENSEN ET AL., GASTROENTEROLOGY, (2001), vol. 121, pages 1275 - 1280
    - IRIZARRY ET AL., BIOSTATISTICS, (2003), vol. 4, pages 249 - 264
    - LANGFELDER ET AL., BMC BIOINFORMATICS, (2008), vol. 9, page 559
 US20070671956
 US20070781166
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.